Observational studyBMC emergency medicine2025
Prognostic value of lactate-to-hemoglobin ratio in nontraumatic critically ill patients presenting to the emergency department: a retrospective cohort study.
Observational study in BMC emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Impact of the Hemoglobin-to-Lactate Ratio (HLR) on Clinical Outcomes and Prognosis in Pneumonia Patients Presenting to the Emergency Department.Diagnostics (Basel, Switzerland) · 2026Article
- Beyond lactate: prognostic value of metabolic and biochemical parameters in methanol poisoning - a retrospective observational study.BMC emergency medicine · 2026Observational
- Mortality prediction in geriatric ICU patients with pneumonia-related sepsis: APACHE II, NEWS, and serum lactate.Biomolecules & biomedicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNontraumatic critically ill patients constitute a substantial cohort of individuals presenting to the emergency department (ED). However, reliable parameters to predict early mortality in these patients are limited. Lactate and base deficit (BD) are commonly used markers reflecting tissue hypoxia and metabolic acidosis, respectively. This study aimed to evaluate the prognostic value of the lactate-to-hemoglobin ratio (LHR), a novel parameter that concurrently reflects imbalances in oxygen delivery and utilization, for predicting in-hospital mortality.
methodsThis retrospective observational study was conducted in the ED of a tertiary care hospital between January 1 and December 31, 2023. Patients aged ≥ 18 years with a lactate level ≥ 4 mmol/L and BD ≤ − 2 mmol/L at presentation were included. Patients with a history of trauma or incomplete data were excluded. Demographic, clinical, and laboratory data were recorded. LHR, lactate clearance, and BD clearance were calculated. The primary endpoint was in-hospital mortality. Logistic regression and receiver operating characteristic curve analysis were used for statistical analysis.
resultsA total of 693 patients were included in the study, of whom 180 (26%) died in the hospital. The median age of the patients was 69 years, and 55.8% were aged ≥ 65 years. Compared to survivors, nonsurvivors had significantly higher lactate levels (6.47 vs. 5.24 mmol/L), higher LHR values (0.62 vs. 0.42), lower lactate clearance (13.35% vs. 51.84%), and more pronounced base deficits (− 10.55 vs. −6.10 mmol/L) (p < 0.001 for all). Multivariate analysis identified age (odds ratio [OR] = 1.043), LHR (OR = 9.033), and BD clearance as independent predictors of mortality. In ROC analysis, the predictive power of LHR (AUC = 0.749) was comparable to lactate clearance (AUC = 0.762) and superior to initial lactate level.
conclusionsThe LHR is a readily accessible and reliable predictor of in-hospital mortality in nontraumatic critically ill patients. Its prognostic performance is comparable to lactate clearance and superior to initial lactate levels. These findings warrant confirmation by prospective, multicenter studies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.